The fourth OncoAlert Colloquium

Year in review in oncology: 2023 in review, one tumor group a day.

February 2024. Seven sessions.

Watch the programThe latest Colloquium

Reviewing 2023

GenitourinaryThe fourth OncoAlert Colloquium, the whole day

Year in review in GU malignancies

The whole session.

Open on YouTube (opens a new tab)

The 2024 program

Seven sessions, each on demand.

Choose a day

Year in review in GU malignancies

Session 1 of 7.

Year in review in breast cancer

Session 2 of 7.

Year in review in gynecologic oncology

Session 3 of 7.

How I treat when I don’t have the treatment

Session 4 of 7.

Year in review in lung cancer

Session 5 of 7.

Year in review in GI malignancies

Session 6 of 7.

Year in review: special sessions

Session 7 of 7.

About this Colloquium

The meeting

  • The most significant advances in oncology in 2023, by cancer type, with medical, radiation, surgical and gynecological oncology faculty.

In partnership with

  • American Society for Radiation Oncology (ASTRO)
  • European Society of Surgical Oncology (ESSO)
  • European Society of Gynaecological Oncology (ESGO)
  • Multinational Association of Supportive Care in Cancer (MASCC)
  • International Society of Geriatric Oncology (SIOG)
  • The OncoAlert Global Consortium

Every Colloquium

  1. The sixth ColloquiumFebruary 2026. Reviewing 2025.The whole program; every talk on demand.
  2. The fifth ColloquiumFebruary 3 to 9, 2025. Reviewing 2024.The whole program, with the day recordings, slides and chats.
  3. The fourth ColloquiumFebruary 2024. Reviewing 2023. You’re here.The session recordings. The program itself was not kept.
  4. The third ColloquiumJanuary 23 to 28, 2023. Reviewing 2022.The announcement. No recordings on the site yet.
  5. The second ColloquiumDate not in the archive.Nothing from it is in the archive yet.
  6. The first ColloquiumDecember 14 to 18, 2020.The announcement. No recordings on the site yet.

The next Colloquium

Nothing is set yet. Leave your email and you’ll hear about it first, with The OncoAlert Newsletter.

Free. Easy to leave.